Literature DB >> 23547093

Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients.

Federico Perez1, David Van Duin.   

Abstract

The emergence of carbapenem-resistant Enterobacteriaceae (CRE) highlights the importance of effective antibiotics to maintain the safety of our health care system. Clinicians will encounter CRE as a cause of difficult-to-treat and often fatal infections in hospitalized patients. We review the mechanisms of carbapenem resistance, the dissemination and clinical impact of these resistant organisms, and challenges to their detection, treatment, and control.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23547093      PMCID： PMC3960994          DOI： 10.3949/ccjm.80a.12182

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  66 in total

1.  First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.

Authors:  Shiri Navon-Venezia; Azita Leavitt; Mitchell J Schwaber; J Kamile Rasheed; Arjun Srinivasan; Jean B Patel; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

2.  Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure.

Authors:  Arjun Srinivasan; Jean B Patel
Journal:  Infect Control Hosp Epidemiol       Date:  2008-12       Impact factor: 3.254

3.  Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.

Authors:  Andrea Endimiani; Lenore L Carias; Andrea M Hujer; Christopher R Bethel; Kristine M Hujer; Federico Perez; Rebecca A Hutton; William R Fox; Geraldine S Hall; Michael R Jacobs; David L Paterson; Louis B Rice; Stephen G Jenkins; Fred C Tenover; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2008-04-21       Impact factor: 5.191

4.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

5.  Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae.

Authors:  Malaika L Little; Xuan Qin; Danielle M Zerr; Scott J Weissman
Journal:  Int J Antimicrob Agents       Date:  2011-11-03       Impact factor: 5.283

6.  Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.

Authors:  Gopi Patel; Shirish Huprikar; Stephanie H Factor; Stephen G Jenkins; David P Calfee
Journal:  Infect Control Hosp Epidemiol       Date:  2008-12       Impact factor: 3.254

7.  Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.

Authors:  Andrea Endimiani; Andrea M Hujer; Federico Perez; Christopher R Bethel; Kristine M Hujer; Jennifer Kroeger; Margret Oethinger; David L Paterson; Mark D Adams; Michael R Jacobs; Daniel J Diekema; Gerri S Hall; Stephen G Jenkins; Louis B Rice; Fred C Tenover; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2009-01-20       Impact factor: 5.790

8.  Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-03-20       Impact factor: 17.586

9.  Trends in antibacterial use in US academic health centers: 2002 to 2006.

Authors:  Amy L Pakyz; Conan MacDougall; Michael Oinonen; Ronald E Polk
Journal:  Arch Intern Med       Date:  2008-11-10

Review 10.  SHEA/APIC Guideline: Infection prevention and control in the long-term care facility.

Authors:  Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson
Journal:  Am J Infect Control       Date:  2008-09       Impact factor: 2.918
View more
  58 in total

1.  The ABCs of the US Broad Spectrum Antimicrobials Program: Antibiotics, Biosecurity, and Congress.

Authors:  John K Billington
Journal:  Health Secur       Date:  2015-11-16

Review 2.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

3.  Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia.

Authors:  Yanling Xu; Bing Gu; Mao Huang; Haiyan Liu; Ting Xu; Wenying Xia; Tong Wang
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

4.  Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know.

Authors:  David van Duin
Journal:  Virulence       Date:  2017-04-12       Impact factor: 5.882

5.  Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae elucidated by single-nucleotide variation analysis: a case investigation.

Authors:  Hideharu Hagiya; Kotaro Aoki; Yukihiro Akeda; Noriko Sakamoto; Norihisa Yamamoto; Hisao Yoshida; Isao Nishi; Yoshikazu Ishii; Kazunori Tomono
Journal:  Infection       Date:  2017-01-30       Impact factor: 3.553

Review 6.  Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature.

Authors:  Nathaniel Aviv Cohen; Nitsan Maharshak
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 7.  Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE).

Authors:  Dana R Bowers; Vanthida Huang
Journal:  Curr Infect Dis Rep       Date:  2016-12       Impact factor: 3.725

8.  Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  David van Duin; Eric Cober; Sandra S Richter; Federico Perez; Robert C Kalayjian; Robert A Salata; Scott Evans; Vance G Fowler; Robert A Bonomo; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2015-05-20       Impact factor: 3.254

Review 9.  Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae.

Authors:  Darren Wong; Brad Spellberg
Journal:  Virulence       Date:  2016-05-17       Impact factor: 5.882

Review 10.  Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

Authors:  David van Duin; David L Paterson
Journal:  Infect Dis Clin North Am       Date:  2016-06       Impact factor: 5.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.